— Know what they know.
Not Investment Advice

NUVA NASDAQ

NuVasive, Inc.
1W: +0.0% 1M: +1.2% 3M: +0.3% 1Y: -12.3% 3Y: -22.2% 5Y: -43.6%
$39.75
Last traded 2023-09-08 — delisted
NASDAQ · Healthcare · Medical - Devices · $2.1B mcap · 52M float · 3.13% daily turnover

Balance Sheet Trends

Total Assets
$2.2B +3.3% ▲
5Y CAGR: +6.3%
Total Liabilities
$1.4B -0.2% ▼
5Y CAGR: +10.0%
Shareholders Equity
$869M +9.3% ▲
5Y CAGR: +1.8%
Cash & Investments
$249M +1.0% ▲
5Y CAGR: +27.8%
Total Debt
$1.0B -0.0% ▼
5Y CAGR: +11.5%
Net Debt
$757M -0.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$118M$213M$857M$246M$249M
Short-Term Investments$0$0$173M$0$0
Cash & ST Investments$118M$213M$1.0B$246M$249M
Net Receivables$196M$212M$207M$214M$249M
Inventory$273M$312M$301M$316M$339M
Other Current Assets$31M$27M$24M$26M$21M
Total Current Assets$618M$764M$1.6B$802M$865M
Property, Plant & Equip.$239M$333M$389M$407M$442M
Goodwill & Intangibles$813M$762M$712M$876M$824M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$32M$16M$15M$21M$25M
Total Non-Current Assets$1.1B$1.1B$1.1B$1.4B$1.4B
Total Assets$1.7B$1.9B$2.7B$2.2B$2.2B
— Liabilities —
Accounts Payable$106M$97M$110M$116M$120M
Short-Term Debt$0$6M$653M$10M$458M
Deferred Revenue$0$88M$65M$67M$0
Other Current Liabilities$74M$16M$7M$8M$138M
Total Current Liabilities$179M$207M$836M$201M$716M
Long-Term Debt$603M$696M$878M$997M$548M
Other Non-Current Liab.$86M$52M$52M$158M$78M
Total Non-Current Liabilities$694M$763M$938M$1.2B$640M
Total Liabilities$873M$970M$1.8B$1.4B$1.4B
— Equity —
Common Stock$61K$62K$62K$63K$63K
Retained Earnings$17M$82M$45M$46M$86M
Accumulated OCI-$9M-$9M-$8M-$8M-$3M
Total Stockholders Equity$835M$915M$919M$795M$869M
Total Liabilities & Equity$1.7B$1.9B$2.7B$2.2B$2.2B
— Key Metrics —
Total Debt$603M$702M$1.5B$1.0B$1.0B
Net Debt$485M$489M$674M$760M$757M
Total Investments$0$0$173M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms